NCT06996691

Brief Summary

Pain control remains challenging in patients undergoing video-assisted thoracoscopic surgery (VATS). It is advised to use a regional block to lower postoperative opioid usage. This study evaluates efficacy of Erector spinae plane (ESP) block in comparison to Serratus anterior plane block (SAP) in pain management for patients undergoing video-assisted thoracoscopic surgery(VATS).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 6, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 30, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2025

Completed
Last Updated

May 30, 2025

Status Verified

February 1, 2025

Enrollment Period

3 months

First QC Date

May 6, 2025

Last Update Submit

May 21, 2025

Conditions

Keywords

VATSErector spinae plane blockSerratus anterior plane block

Outcome Measures

Primary Outcomes (1)

  • post operative opioid consumption

    post operative meperidine consumption throughout

    24 hours post operative

Secondary Outcomes (2)

  • intraoperative fentanyl consumption

    during the surgery

  • the numerical rating scale

    24 hours post operative

Study Arms (2)

Group A: Erector spinae block group

ACTIVE COMPARATOR

After selecting the target transverse process for the nerve block, place the transducer in a paramedian sagittal orientation, approximately 2cm away from the midline (spinous processes), and try to vizualize the transverse process at the level of T5 Complete the nerve block with 30ml of 0.25% levobupivacaine for erector spinae block

Procedure: Erector Spinae Plane Block (ESPB) group

group B: Serratus anterior block group

ACTIVE COMPARATOR

High-frequency linear transducer should be placed on the patient's midaxillary line in the transverse plane, at the level of the fifth rib. With the rib, pleural line, and overlying serratus anterior and latissimus dorsi muscles visualized. Then, using ultrasound guidance, the needle is advanced in-plane and the local anesthetic is injected anteriorly to the rib and deep to the serratus anterior. After opening the fascial plane, a volume of dilute local anesthetic, 30 mL of 0.25% levobupivacaine, should be gradually injected.

Procedure: Serratus Anterior Plane Block (SAPB) group

Interventions

30ml of 0.25% levobupivacaine for erector spinae block at level of T5

Group A: Erector spinae block group

30 mL of 0.25% levobupivacaine injected anteriorly to the rib and deep to the serratus anterior at level of 5 th rib

group B: Serratus anterior block group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • body mass index (BMI)=18 to 40 kg/m2

You may not qualify if:

  • Contraindications to regional anesthesia as bleeding disorders , allergy to local anesthetic or infection at block site
  • pre-existing chronic pain
  • history of opiate abuse
  • sepsis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of medicine Ain Shams University

Cairo, 02, Egypt

RECRUITING

MeSH Terms

Interventions

Population GroupsSaposins

Intervention Hierarchy (Ancestors)

DemographyPopulation CharacteristicsSphingolipid Activator ProteinsCoenzymesEnzymes and Coenzymes

Central Study Contacts

abdallah M soudi, M.D.56k

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2025

First Posted

May 30, 2025

Study Start

May 1, 2025

Primary Completion

July 31, 2025

Study Completion

August 15, 2025

Last Updated

May 30, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations